Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WCN
876
Waste Connections
WCN
$42.1B
| $41.2M | 0.01% |
234,945
-17,463
| -7% | -$3.02M |
|
877
Zimmer Biomet
ZBH
$18.6B
| $41.2M | 0.01% |
458,029
-31,027
| -6% | -$2.94M |
|
878
iShares MSCI India ETF
INDA
$6.61B
| $41.2M | 0.01% |
761,977
+209,765
| +38% | +$11.3M |
|
879
Aecom
ACM
$8.7B
| $40.8M | 0.01% |
428,059
-62,767
| -13% | -$7.38M |
|
880
Crane Co
CR
$12.9B
| $40.7M | 0.01% |
220,782
+60,881
| +38% | +$11.3M |
|
881
Energy Transfer Partners
ET
$71.3B
| $40.6M | 0.01% |
2,461,768
+84,708
| +4% | +$1.41M |
|
882
McCormick & Company Non-Voting
MKC
$14.2B
| $40.6M | 0.01% |
595,809
-129,000
| -18% | -$8.57M |
|
883
PUT
Johnson & Johnson
JNJ
$626B
| $40.4M | 0.01% |
195,100
-5,500
| -3% | -$1.09M |
|
884
NMI Holdings
NMIH
$3.34B
| $40.4M | 0.01% |
989,364
-115,516
| -10% | -$4.37M |
|
885
Crocs
CROX
$6.44B
| $40.2M | 0.01% |
469,623
-35,908
| -7% | -$3M |
|
886
Gartner
IT
$12B
| $39.9M | 0.01% |
158,267
-94,254
| -37% | -$22.7M |
|
887
CALL
Cloudflare
NET
$111B
| $39.9M | 0.01% |
202,500
| – | – |
|
888
PUT
Brinker International
EAT
$9.75B
| $39.8M | 0.01% |
277,400
+177,400
| +177% | +$23.2M |
|
889
PUT
Constellation Brands
STZ
$22.6B
| $39.7M | 0.01% |
287,600
+256,000
| +810% | +$35.1M |
|
890
Remitly
RELY
$5.04B
| $39.6M | 0.01% |
2,866,139
-700,370
| -20% | -$10.2M |
|
891
EXL Service
EXLS
$5.36B
| $39.6M | 0.01% |
931,953
+355,750
| +62% | +$14.5M |
|
892
Huntington Ingalls Industries
HII
$13.1B
| $39.5M | 0.01% |
116,188
-3,666
| -3% | -$1.14M |
|
893
IonQ
IONQ
$17.4B
| $39.4M | 0.01% |
878,495
+453,852
| +107% | +$25.4M |
|
894
Franklin Resources
BEN
$17B
| $39.4M | 0.01% |
1,649,569
+503,831
| +44% | +$11.6M |
|
895
F5
FFIV
$23.4B
| $39.4M | 0.01% |
154,366
-156,002
| -50% | -$42M |
|
896
Molina Healthcare
MOH
$10.3B
| $39.3M | 0.01% |
226,430
+116,356
| +106% | +$19.1M |
|
897
CALL
Estee Lauder
EL
$32B
| $39.3M | 0.01% |
375,000
-520,000
| -58% | -$50.5M |
|
898
DuPont de Nemours
DD
$19.6B
| $39.1M | 0.01% |
324,511
-1,270,317
| -80% | -$143M |
|
899
West Pharmaceutical
WST
$24.7B
| $39.1M | 0.01% |
142,185
+2,169
| +2% | +$593K |
|
900
Darden Restaurants
DRI
$24.9B
| $39M | 0.01% |
212,096
-69,691
| -25% | -$12.7M |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.